23 results
8-K
EX-99.2
AXDX
Accelerate Diagnostics Inc
13 Jan 21
Accelerate Diagnostics Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results
9:45am
.2020.07.016. Antimicrobial resistance rates expected to increase due to: Spike in use of antibiotics Pausing of stewardship programs Resources diverted from … commercial and operational execution
Synergistic Partnerships DIAGNOSTIC STEWARDSHIP ANTIBIOTIC STEWARDSHIP Clinical Patient Evaluation Testing
8-K
EX-99.1
AXDX
Accelerate Diagnostics Inc
13 Dec 23
December 2023 Company Presentation
5:05pm
Introduced first fully automated, FDA-approved, rapid PBC susceptibility kit to market Catalyst for Antimicrobial Stewardship best practices … with demonstrated improvements to clinical outcomes Strong base of existing customers who have adopted Pheno® and established stewardship and clinical workflow best
8-K
EX-99.1
AXDX
Accelerate Diagnostics Inc
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
) Walsh et al. Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients … Society of America. 2020 May. DOI: 10.1093/cid/ciaa649 (5) MacVane et al. Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram
8-K
EX-99.2
AXDX
Accelerate Diagnostics Inc
12 Nov 21
Accelerate Diagnostics Reports Second Quarter 2021 Financial Results
4:12pm
focus on COVID, but having said that, beyond that, I mean stewardship teams are starting to reorganize which is very important for our business
8-K
EX-99.2
uqodqpr6sb
14 May 18
Accelerate Diagnostics reports Q1 2018 financial results
5:29pm
424B5
jcy lfe6w
28 May 21
Prospectus supplement for primary offering
5:24pm
424B5
w61uk jgrz2s0r
17 Aug 22
Prospectus supplement for primary offering
6:13pm
424B5
hgzl4f8o b8tgudrkh
22 Aug 22
Prospectus supplement for primary offering
4:11pm